$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 27 Jul 2016 | 27174 | In Stock
Related Topics: Anxiety Disorders , Clinical Trials

Introduction

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016" provides an overview of Social Anxiety Disorders (SAD) clinical trials scenario. This report provides top line data relating to the clinical trials on Social Anxiety Disorders (SAD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Top Countries Contributing to Clinical Trials in Central and South America 13

    Clinical Trials by G7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 17

    Clinical Trials by Phase in E7 Countries 18

    Clinical Trials in E7 Countries by Trial Status 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Social Anxiety Disorders (SAD) Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Clinical Trial Profile Snapshots 30

    Appendix 88

    Abbreviations 88

    Definitions 88

    Research Methodology 89

    Secondary Research 89

    About GlobalData 90

    Contact Us 90

    Disclaimer 90

    Source 91

List Of Tables
in Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016

List of Tables

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Region, 2016* 6

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13

Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14

Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17

Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Social Anxiety Disorders (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016

List of Figures

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13

Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14

Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17

Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Social Anxiety Disorders (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 89

Additional Details

Publisher

Global Data

Publisher Information

Reference

27174 | GDHC3579CTIDB

Number of Pages

91

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Smart Education and Learning Market by Product (Hardware, Software, Service, Educational Content), User (Academic, Corporate), Learning Mode (Collaborative, Virtual Instructor, Simulation, Adaptive, Social, Blended), and Region - Global Forecast to 2021
“Increasing eLearning in the corporate and academic setups and widespread government initiatives is ...
06 Dec 2016 by MarketsandMarkets USD $7,150 More Info
Digital Transformation Market by Solution (Cloud Computing, Big Data, Mobility, and Social Media), Service (Professional and System Integrators), Business Type (B2B, B2B2C, & B2C), End User, Deployment type, Vertical, and Region - Global Forecast to 2021
“Increasing demand for internet of things and increased penetration of mobile devices and apps drive...
14 Nov 2016 by MarketsandMarkets USD $7,150 More Info
Penetration Testing Market by Testing Service (Network, Web, Mobile, Social Engineering, Wireless, Embedded Devices and Industrial Control System), Deployment Mode (Cloud and On-Premises), Organization Size, Vertical, and Region - Global Forecast to 2021
“Increased sophistication level in attacking techniques is driving the growth of the penetration tes...
30 Aug 2016 by MarketsandMarkets USD $5,650 More Info
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical t...
27 Jul 2016 by Global Data USD $2,500 More Info
Digital Marketing Software Market by Software (CRM, E-mail, Ecommerce, Marketing Automation, Web Analytics, Web Content Management & Social CRM), by Deployment (On-Premise, Cloud), by Verticals (BFSI, Retail, Manufacturing, & others) - Global Forecast to 2019
The Digital Marketing software (DMS) market is fast gaining traction primarily due to the increase i...
13 Mar 2015 by MarketsandMarkets USD $7,150 More Info
Cloud Collaboration Market by Solution (Enterprise Content Management/ Document Management System, Unified Communication, Project Management, Enterprise Social Collaboration) – Worldwide Forecast and Analysis (2014 – 2019)
Cloud collaboration is a new method of sharing the documents and computer related files where they c...
20 Jan 2015 by MarketsandMarkets USD $5,650 More Info
Social Customer Relationship Management (CRM) Market by Solution (Social Monitoring, Social Listening, Social Mapping, Social Measurements, Social Engagement, Social Middleware), by Deployment (Hosted, On Premise) – Global Forecasts to 2019
Advancements in Social CRM have made it faster, reachable and have also brought in vital information...
16 Jan 2015 by MarketsandMarkets USD $7,150 More Info
Social and Mobile Pharma - the State of the Digital Landscape
IntroductionTightly-regulated and conservative in outlook, the pharmaceutical industry has largely b...
01 Nov 2012 by FirstWord Pharma USD $695 More Info
Tapping Social Media for Clinical Trial Recruitment
IntroductionWith an estimated 80% of all clinical trials failing to achieve enrolment goals, sponsor...
01 Apr 2012 by FirstWord Pharma USD $695 More Info
KOL Relationship Development: Leveraging Social Media Platforms
IntroductionFor years, their voices went unheard. And their opinions were ignored. But not anymore. ...
01 Jan 2012 by FirstWord Pharma USD $595 More Info

This report is published by Global Data

Download Free Report Summary PDF

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...